Assay ID | Title | Year | Journal | Article |
AID1359333 | Induction of melanogenesis in mouse Melan-a cells assessed as effect on tanning property at 40 uM after 48 hrs | 2018 | European journal of medicinal chemistry, May-25, Volume: 152 | Natural oxyprenylated coumarins are modulators of melanogenesis. |
AID306626 | Inhibition of FTase at 100 uM | 2007 | Bioorganic & medicinal chemistry letters, May-01, Volume: 17, Issue:9
| Prenyloxyphenylpropanoids as novel lead compounds for the selective inhibition of geranylgeranyl transferase I. |
AID449576 | Anticonvulsant activity in mouse at 300 mg/kg, ip after 120 mins by MES test | 2009 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 19, Issue:18
| Prenyloxyphenylpropanoids as a novel class of anticonvulsive agents. |
AID659716 | Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 100 uM after 24 hrs by dual-luciferase assay relative to control | 2012 | Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
| Nelumal A, the active principle from Ligularia nelumbifolia, is a novel farnesoid X receptor agonist. |
AID117727 | Percent uM/cm**2 | 2004 | Bioorganic & medicinal chemistry letters, May-03, Volume: 14, Issue:9
| Synthesis and anti-inflammatory activity of natural and semisynthetic geranyloxycoumarins. |
AID110864 | Inhibitory activity against mouse uM/cm**2 (control=7.0) | 2004 | Bioorganic & medicinal chemistry letters, May-03, Volume: 14, Issue:9
| Synthesis and anti-inflammatory activity of natural and semisynthetic geranyloxycoumarins. |
AID659712 | Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 5 uM after 24 hrs by dual-luciferase assay relative to control | 2012 | Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
| Nelumal A, the active principle from Ligularia nelumbifolia, is a novel farnesoid X receptor agonist. |
AID659711 | Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 1 uM after 24 hrs by dual-luciferase assay relative to control | 2012 | Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
| Nelumal A, the active principle from Ligularia nelumbifolia, is a novel farnesoid X receptor agonist. |
AID659717 | Agonist activity at human farnesoid X receptor expressed in human HepG2 cells after 24 hrs by dual-luciferase assay relative to control | 2012 | Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
| Nelumal A, the active principle from Ligularia nelumbifolia, is a novel farnesoid X receptor agonist. |
AID659715 | Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 50 uM after 24 hrs by dual-luciferase assay relative to control | 2012 | Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
| Nelumal A, the active principle from Ligularia nelumbifolia, is a novel farnesoid X receptor agonist. |
AID1359332 | Cytotoxicity against mouse Melan-a cells assessed as effect on cell viability at <2 uM after 24 to 72 hrs by trypan blue exclusion assay | 2018 | European journal of medicinal chemistry, May-25, Volume: 152 | Natural oxyprenylated coumarins are modulators of melanogenesis. |
AID306627 | Inhibition of GGTase 1 at 100 uM | 2007 | Bioorganic & medicinal chemistry letters, May-01, Volume: 17, Issue:9
| Prenyloxyphenylpropanoids as novel lead compounds for the selective inhibition of geranylgeranyl transferase I. |
AID659713 | Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 10 uM after 24 hrs by dual-luciferase assay relative to control | 2012 | Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
| Nelumal A, the active principle from Ligularia nelumbifolia, is a novel farnesoid X receptor agonist. |
AID1359334 | Inhibition of melanogenesis in mouse Melan-a cells assessed as effect on whitening property at 40 uM after 48 hrs | 2018 | European journal of medicinal chemistry, May-25, Volume: 152 | Natural oxyprenylated coumarins are modulators of melanogenesis. |
AID659714 | Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 25 uM after 24 hrs by dual-luciferase assay relative to control | 2012 | Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
| Nelumal A, the active principle from Ligularia nelumbifolia, is a novel farnesoid X receptor agonist. |
AID659710 | Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 0.1 uM after 24 hrs by dual-luciferase assay relative to control | 2012 | Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
| Nelumal A, the active principle from Ligularia nelumbifolia, is a novel farnesoid X receptor agonist. |
AID449574 | Anticonvulsant activity in mouse at 300 mg/kg, ip after 30 mins by MES test | 2009 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 19, Issue:18
| Prenyloxyphenylpropanoids as a novel class of anticonvulsive agents. |
AID1357276 | Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production | 2018 | European journal of medicinal chemistry, Jun-10, Volume: 153 | Recent acquisitions on oxyprenylated secondary metabolites as anti-inflammatory agents. |
AID449573 | Anticonvulsant activity in mouse at 300 mg/kg, ip after 15 mins by MES test | 2009 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 19, Issue:18
| Prenyloxyphenylpropanoids as a novel class of anticonvulsive agents. |
AID449575 | Anticonvulsant activity in mouse at 300 mg/kg, ip after 60 mins by MES test | 2009 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 19, Issue:18
| Prenyloxyphenylpropanoids as a novel class of anticonvulsive agents. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |